hamd

HAMD and CGI were used to evaluate the treatment effects .

采用HAMD、CGI评定疗效。

The curative effects were evaluated with HAMD scale .

采用HAMD量表评定疗效。

Characteristics of HAMD at Different Stages after Cerebral Concussion

脑震荡患者不同阶段的抑郁症状表现

26 met severe depression criteria of HAMD , accounting for 13.3 % .

重度为26例，占抑郁情绪障碍患者的13.3%。

The mean accuracy was negatively correlated with the HAMD scores in depression .

抑郁组的警觉网络效率与汉密尔顿抑郁量表得分的睡眠障碍因子分呈负相关，平均正确率与汉密尔顿抑郁量表得分呈负相关。

HAMD score changes before and after treatment , HAMD score after treatment were significantly reduced .

治疗前后HAMD评分变化，治疗后两组HAMD评分均有明显下降。

Results : The values of HAMD and CSS had no differences before treatment , p > 0.05 ;

结果治疗组与对照组之间的HAMD评分和CSS评分在治疗前无差别（p>0.05）；

Results The score of HAMD decreased significantly at the end of1 week posttreatment .

结果治疗第1w末，汉密顿抑郁量表评分较治疗前减少，差异有显著性；

Results : The results of ITAQ were consistent with clinical standard , while significantly different with HAMD .

结果：ITAQ与临床标准评定结果一致，与HAMD评定结果差异显著。

According to total score of HAMD , they were divided depressive group and non depressive group .

以HAMD总分20分为界限分为抑郁组和非抑郁组。

All patients were evaluated with the HAMD , HAMA scales .

分别评定HAMD、HAMA量表。

HAMD and Neurological Functional Deficit Scales were performed 6 and 12 weeks after treatment .

治疗6及12周后采用HAMD、神经功能缺损评分及副反应量表（TESS）评定。

The efficacy was assessed by Hamilton Depression Rating Scale ( HAMD ) .

用汉密顿抑郁量表（HAMD）、不良反应量表（TESS）分别评定疗效和不良反应。

There was no significant difference on the basic HAMD scores among different genotypic patients ( P > 0.05 ) .

入组时，不同基因型的患者之间HAMD基础评分的差异无显著性（P>005）。

Correlation analysis between factor scores and syndrome essence of hamilton depression scale ( HAMD ) in patients with depression

抑郁症患者HAMD量表因子分与证候要素的相关性分析

Using HAMA and HAMD , We tested the psychological disorders in 117 patients with systemic disease .

采用HAMA和HAMD检测117例内科疾病患者的心理障碍。

Methods 162 HIV / AIDS patients were investigated with SCL-90 , HAMA , HAMD .

方法采用90项症状清单（SCL&90）、汉密顿焦虑量表（HAMA）、汉密顿抑郁量表（HAMD）对162例HIV感染者/AIDS患者进行调查。

Results There were significantly higher total score and factor score of HAMD in depressive group than non depressive group .

结果两组HAMD总分及因子分的差异有统计学意义，抑郁组均高于非抑郁组。

HAMD , HAMA and CGI were adopted to evaluate the efficacy .

疗效评定采用HAMD，HAMA及CGI。

Changes of depressive symptoms and side reactions were assessed with the HAMD and TESS respectively .

以汉密顿抑郁量表（HAMD）评价抑郁症状变化，以副反应症状量表（TESS）评定副反应。

MAIN OUTCOME MEASURES : Nerve deficiency , ADL , HAMD , SDS and SAS scores .

主要观察指标：神经功能缺损，ADL，HAMD，SDS，SAS评分。

Only the dilatoriness has significant difference in the all items of HAMD .

HAMD各条目中仅有迟缓存在统计学差异。

And after treatment for 4 weeks and 8 weeks , an evaluation was made by means of HAMD scale and ADL scale .

分别观察用药4周和用药8周后临床疗效，以及HAMD评分和ADL评分变化。

Method : Forty one depressive patients were evaluated with HAMD , SCL 90 and self designed inquisitional table .

方法：采用汉密尔顿抑郁量表（HAMD），症状自评量表（SCL-90）及自编的抑郁患者躯体症状调查表，对41例患者进行评定。

We used Hamilton Rating Scales of Depression ( HAMD ) to assess the severity of depressive state .

方法：1.采用17项汉密尔顿抑郁量表（HAMD）评定抑郁症状严重程度；

Results Compared with pretreatment , scores of the HAMD in each week during treatment significantly decreased for both groups ( P < 0.01 );

结果两组治疗后各周汉密顿抑郁量表评分均较治疗前显著下降（P<0.01）；

Efficacy was evaluated by HAMD .

疗效评定采用HAMD减分率。

MESSS and HAMD were used for assessing treatment effects before and after treatments for 4 and 8 weeks .

在治疗前和治疗后4周及8周分别用改良爱丁堡斯堪的那维亚卒中量表（MESSS）和汉密尔顿抑郁量表（HAMD）评定疗效。

HAMD and HAMA estimations were most significantly different pre and after treatment ( P < 0 01 ) .

两组治疗后与治疗前比较HAMD、HAMA差异均有极显著意义（P<0.01）。

There was no significant difference in the scores of HAMA , HAMD and BDI between the two groups .

精神病性和STAI得分药物治疗组较心理治疗组下降幅度更大（P<005）；HAMA、HAMD、BDI分数两组间无明显差异。